Neuroone Medical Technologies (NMTC) Liabilities from Discontinued Operations (2015 - 2016)

Neuroone Medical Technologies (NMTC) posted Liabilities from Discontinued Operations of 21807.0 for Q4 2016, little changed on a QoQ basis from 21807.0 in Q3 2016, and up 10.02% year-over-year from 19821.0 in Q1 2016.

Neuroone Medical Technologies (NMTC) Liabilities from Discontinued Operations (2015 - 2016) Analysis & Trends

Neuroone Medical Technologies' Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 21807.0 for Q4 2016.

  • Quarterly Liabilities from Discontinued Operations rose 10.02% year-over-year to 21807.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was 21807.0 (up 10.02% YoY) and the FY2016 annual result came in at 21807.0, up 10.02% from the prior year.
  • Liabilities from Discontinued Operations was 21807.0 for Q4 2016 at Neuroone Medical Technologies, roughly flat from 21807.0 in the prior quarter.
  • Across five years, Liabilities from Discontinued Operations topped out at 21807.0 in Q2 2016 and bottomed at 19821.0 in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Neuroone Medical Technologies 7.99 Mn 5.19 Mn 990,264.00

Historic Data

Download Data
DateValue
Dec 31, 2016 21,807.00
Dec 31, 2016 21,807.00
Sep 30, 2016 21,807.00
Sep 30, 2016 21,807.00
Jun 30, 2016 21,807.00
Jun 30, 2016 21,807.00
Dec 31, 2015 19,821.00
Dec 31, 2015 19,821.00